Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05532982 · ClinicalTrials.gov registry record
Parkinson's Disease in Asian Americans
A clinical trial of Parkinson's Disease, sponsored by Tufts University.
- Recruiting
- Registry status
- 430
- Enrollment target
- 1
- Study location
NCT05532982: Recruiting study of Parkinson's Disease, sponsored by Tufts University.
NCT05532982 is a study of Parkinson's Disease that is actively recruiting participants, run by Tufts University. The registered enrollment target is 430 participants, below the 633-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (32% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05532982, a study of Parkinson's Disease, is actively recruiting participants, sponsored by Tufts University.
- RECRUITING
- Registry status
- 430 participants
- Enrollment target
- 1
- Study location
Study Summary
The ultimate goal of this project is to use the findings to develop culturally appropriate programs and resources that can be disseminated to key stakeholders to improve access to PD care and increase inclusivity in PD research for Asian Americans. This study will serve as a first step towards developing broader community and patient education programs and active outreach campaigns to increase PD-specific literacy among Asian Americans. The results from this study will elucidate the role that language barriers, cultural perceptions, family influence, and other predisposing, enabling, or need factors have on delaying care for PD among Asian Americans. It will also provide much needed insight on how to improve inclusion of Asian Americans in PD research studies.
Conditions Studied
Interventions
- OTHER Interviews and Surveys
Study Locations (1)
Massachusetts
- Tufts University School of Medicine - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 430 participants |
| Start Date | 2022-10-15 |
| Est. Completion | 2024-11-30 |
What NCT05532982 shows while recruiting
NCT05532982 is an observational study that tracks outcomes without assigning an intervention. The registered 430 participants enrollment target is mid-sized for trials with a published cap, below the 633-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (32% lower).
The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 1 intervention - of which Interviews and Surveys is the first listed.
NCT05532982 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05532982 about?
NCT05532982 is a clinical study titled "Parkinson's Disease in Asian Americans". The ultimate goal of this project is to use the findings to develop culturally appropriate programs and resources that can be disseminated to key stakeholders to improve access to PD care and increase inclusivity in PD research for Asian Americans. This study will serve as a first step towards devel...
What is the current status of trial NCT05532982?
This trial is currently recruiting. The enrollment target is 430 participants. The study started on 2022-10-15. Estimated completion is 2024-11-30.
What conditions does trial NCT05532982 study?
This clinical trial studies the following conditions: Parkinson's Disease.
What interventions are being tested in trial NCT05532982?
The interventions under investigation include: Interviews and Surveys (OTHER).
Who is sponsoring clinical trial NCT05532982?
This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05532982 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson's Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05532982's enrollment target sits among peer trials
430 19th of 158 higher than 140 of 158 other Parkinson's Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Parkinson's Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Novel DBS Stimulation Patterns for Treatment of Parkinson's Disease
RECRUITING · NA
-
rTMS to Improve Cognition in Parkinson's
RECRUITING · Phase 1
-
Deep Brain Stimulation for Visuomotor Function in Parkinson's Disease
RECRUITING
-
Ketamine for Veterans With Parkinson's Disease
RECRUITING · Phase 2
-
Feasibility and Safety of a Portable Exoskeleton to Improve Mobility in Parkinson's Disease
RECRUITING · NA
-
PET Imaging Evaluation of [11C]SY08
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05327023 · 430 participants · Phase 1
Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
- NCT05457985 · 430 participants · NA
Testing Adaptive Interventions to Improve Posttraumatic Stress Disorder Treatment Outcomes in Federally Qualified Health Centers
- NCT05844891 · 430 participants · NA
Telehealth-Enhanced Asthma Care for Home After the Emergency Room
- NCT05867251 · 430 participants · Phase 1
Study of AVZO-021 in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI